阿巴拉契亚地区原发性脑及其他中枢神经系统肿瘤:发病率、死亡率和生存率的区域差异
该研究基于2006至2015年美国中枢脑肿瘤登记数据,比较阿巴拉契亚与非阿巴拉契亚地区原发性脑及其他中枢神经系统肿瘤的发病率、死亡率和生存率。阿巴拉契亚地区恶性PBT发病率高5%,非恶性PBT发病率低3%,恶性PBT死亡率为4.86/10万 vs 4.34/10万,5年相对生存率较低(31.4% vs 36.0%)。
要点
- 阿巴拉契亚地区恶性原发性脑肿瘤发病率较非阿巴拉契亚高5%。
- 阿巴拉契亚地区恶性原发性脑肿瘤5年相对生存率为31.4%,低于非阿巴拉契亚的36.0%。
- 阿巴拉契亚地区恶性原发性脑肿瘤死亡率为4.86/10万,高于非阿巴拉契亚的4.34/10万。
核心结论
- 阿巴拉契亚地区恶性原发性脑及其他中枢神经系统肿瘤发病率升高、非恶性发病率降低,且恶性PBT生存结局较非阿巴拉契亚地区更差。
研究设计与样本
- 数据来源于2006至2015年美国中枢脑肿瘤登记库(由CDC和NCI提供),阿巴拉契亚县按阿巴拉契亚区域委员会方案分类,计算总体及组织学特异性年龄调整发病率和死亡率(每10万人口),并利用CDC国家癌症登记项目2001至2014年数据估算1年、5年和10年相对生存率。
主要发现
- 阿巴拉契亚地区总体PBT发病率为22.62/10万,与非阿巴拉契亚美国(22.77/10万)无显著差异(p=0.1189)。
- 阿巴拉契亚地区恶性PBT发病率较非阿巴拉契亚高5%(7.55/10万 vs 7.23/10万,p<0.0001)。
- 阿巴拉契亚地区非恶性PBT发病率较非阿巴拉契亚低3%(15.07/10万 vs 15.54/10万,p<0.0001)。
- 阿巴拉契亚地区恶性PBT 5年相对生存率较低(31.4% vs 36.0%)。
- 阿巴拉契亚地区恶性PBT死亡率较高(4.86/10万 vs 4.34/10万,p<0.0001)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Appalachian region is a large geographic and economic area, representing 7.69% of the United States (US). This region is more rural, whiter, older, and has a higher level of poverty as compared to the rest of the US. Limited research has been done on primary brain and other central nervous system tumors (PBT) epidemiology in this region. In this analysis we characterize incidence, mortality, and survival patterns. METHODS: Data from 2006 to 2015 were obtained from the central brain tumor registry of the US (provided by CDC and NCI). Appalachian counties were categorized using the Appalachia Regional Council scheme. Overall and histology-specific age-adjusted incidence and mortality rates per 100,000 population were generated. 1-, 5-, and 10-year relative survival (RS) was estimated using CDC national program of cancer registry data from 2001 to 2014. RESULTS: Overall PBT incidence within Appalachia was 22.62 per 100,000, which is not significantly different from the non-Appalachian US (22.77/100,000, p = 0.1189). Malignant incidence was 5% higher in Appalachia (7.55/100,000 vs. 7.23/100,000, p < 0.0001), while non-malignant incidence was 3% lower (15.07/100,000 vs. 15.54/100,000, p < 0.0001). 5-year RS for malignant PBT was lower (31.4% vs. 36.0%), and mortality due to malignant PBT was higher in Appalachia (4.86/100,000 vs. 4.34/100,000, p < 0.0001). CONCLUSION: Appalachia has increased malignant and decreased non-malignant PBT incidence, and poorer survival outcomes for malignant PBT compared to the non-Appalachian US.
引用
- Ostrom QT, Gittleman H, Kruchko C, et al. Primary brain and other central nervous system tumors in Appalachia: regional differences in incidence, mortality, and survival. J Neurooncol. 2018. PMID: 30543034. doi:10.1007/s11060-018-03073-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。